What are the survival rates for metastatic Ovarian Cancer
Survival Rates for Metastatic Ovarian Cancer
I appreciate this important question. However, I need to be direct with you: survival statistics for metastatic ovarian cancer are complex and vary significantly based on individual factors, and the NCCN Guidelines provided don't include specific survival rate percentages.
Why Survival Rates Are Difficult to Quote
According to NCCN Guidelines for Ovarian Cancer, survival outcomes depend heavily on:
- Stage at diagnosis (metastatic ovarian cancer is typically Stage IV)
- Histologic type (high-grade serous, clear cell, mucinous, endometrioid, etc.)
- Surgical outcome (how completely the cancer was removed)
- Response to chemotherapy (whether tumors shrink with treatment)
- Biomarker status (BRCA mutations, HRD status - these significantly impact treatment options and outcomes)
- Overall health and performance status
What the Guidelines Tell Us
The NCCN Guidelines emphasize that metastatic ovarian cancer is treated with:
- Platinum-based chemotherapy (typically carboplatin + paclitaxel)
- Maintenance therapy options including PARP inhibitors (like olaparib) if certain biomarkers are present
- Possible bevacizumab (an anti-angiogenic drug that helps block tumor blood supply)
Patients with BRCA mutations or other homologous recombination deficiency (HRD) markers typically have better responses to these treatments, which can extend survival.
Questions to Ask Your Oncologist
Rather than relying on general statistics, I'd recommend asking your care team:
- "Based on my specific cancer type, stage, and biomarker results, what is my prognosis?"
- "What are the typical response rates to the treatment plan you're recommending for my situation?"
- "Have I been tested for BRCA mutations or HRD status? If so, how do these results affect my treatment options?"
- "What does 'progression-free survival' and 'overall survival' mean in the context of my treatment?"
- "Are there clinical trials available that might be appropriate for my case?"
Why This Matters
Your individual prognosis depends far more on your specific cancer characteristics and how it responds to treatment than on population-wide statistics. Your oncologist has access to your complete medical picture and can provide much more meaningful information than general survival rates.
According to NCCN Guidelines, the focus for metastatic ovarian cancer is on achieving the best possible response to initial treatment and then managing recurrence with additional therapeutic options as they become necessary.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific situation.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Ovarian Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 15, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Ovarian Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with prognosis for Ovarian Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Ovarian Cancer
- Is surgery an option for metastatic Ovarian Cancer
- What questions should I ask my oncologist about metastatic Ovarian Cancer
- What biomarker testing is recommended for metastatic Ovarian Cancer
- What clinical trials are available for metastatic Ovarian Cancer
- What is the difference between early stage and metastatic Ovarian Cancer
- What is the standard of care for metastatic Ovarian Cancer according to NCCN guidelines
- How long do I have to live with Ovarian Cancer
- What does progression mean for Ovarian Cancer and what happens next